Cleared Traditional

K261039 - i-STAT Crea cartridge with the i-STAT 1...

K261039 is an FDA 510(k) clearance for i-STAT Crea cartridge with the i-STAT 1..., manufactured by Abbott Point of Care, Inc.. The device is a Class 2 Chemistry device with product code CGL cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K261039 · Abbott Point of Care, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2026
Decision
88d
Days
Class 2
Risk

K261039 is an FDA 510(k) clearance for the i-STAT Crea cartridge with the i-STAT 1 System. Classified as Electrode, Ion Based, Enzymatic, Creatinine (product code CGL), Class II - Special Controls.

Submitted by Abbott Point of Care, Inc. (Princeton, US). The FDA issued a Cleared decision on June 26, 2026 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1225 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Point of Care, Inc. devices

FDA 510(k) Submission Details - K261039

510(k) Number K261039 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 30, 2026
Decision Date June 26, 2026
Days to Decision 88 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
At panel average
Panel avg: 88d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CGL Device Classification - Class 2, Special Controls

Product Code CGL Electrode, Ion Based, Enzymatic, Creatinine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGL Electrode, Ion Based, Enzymatic, Creatinine

Devices cleared under the same product code (CGL) and FDA review panel - the closest regulatory comparables to K261039.
Nova StatSensor Creatinine Hospital Meter System
K171059 · Nova Biomedical Corporation · May 2017
NOVA STATSENSOR CREATININE HOSPITAL METER, CONTROL SOLUTIONS,LINEARITY SOLUTIONS, AND TEST STRIPS
K070068 · Nova Biomedical Corp. · May 2007
ABL8X7 FLEX
K051968 · Radiometer Medical Aps · Oct 2006
STAT PROFILE M7 ANALYZER
K991727 · Nova Biomedical Corp. · Jul 1999